Full Press Release Details
Lexicon Initiates Phase 3 Clinical Trial Of Telotristat Etiprate In Patients With Carcinoid Syndrome.
LXRX
Lexicon Initiates Phase 3 Clinical Trial Of Telotristat Etiprate In Patients With Carcinoid Syndrome
Key Takeaway: Lexicon Initiates Phase 3 Clinical Trial Of Telotristat Etiprate In Patients With Carcinoid Syndrome